A Controlled Trial of Valganciclovir as Induction Therapy for Cytomegalovirus Retinitis
D. F. Martin
and Others
- 11 Apr, 2002
This
PowerPoint Slide Set is a value
added service that requires an individual subscription.
Already a print subscriber? Activate your online access
Not a Subscriber?
Get full access to NEJM Online now with a FREE TRIAL!
Or, purchase full access to this
PowerPoint Slide Set for $10
